z-logo
open-access-imgOpen Access
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
Author(s) -
Alexandra C. Walls,
Kaitlin R. Sprouse,
John E. Bowen,
Anshu Joshi,
Nicholas Franko,
Mary Jane Navarro,
Cameron Stewart,
Elisabetta Cameroni,
Matthew McCallum,
Erin Goecker,
Emily Degli-Angeli,
Jenni Logue,
Alexander L. Greninger,
Davide Corti,
Helen Y. Chu,
David Veesler
Publication year - 2022
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2022.01.011
Subject(s) - neutralizing antibody , biology , immunology , antibody , neutralization , virology , immunity , antibody response , covid-19 , pandemic , vaccination , anthrax vaccines , antibody dependent enhancement , immune system , virus , immunization , medicine , disease , infectious disease (medical specialty) , viral replication , dna vaccination

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom